AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Up 109.3% in August

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant increase in short interest in August. As of August 14th, there was short interest totaling 183,426 shares, an increase of 109.3% from the July 30th total of 87,636 shares. Based on an average daily trading volume, of 2,836,488 shares, the short-interest ratio is presently 0.1 days. Approximately 3.6% of the shares of the stock are short sold.

Institutional Trading of AquaBounty Technologies

Several institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in shares of AquaBounty Technologies in the 2nd quarter valued at about $51,000. Two Sigma Investments LP bought a new stake in shares of AquaBounty Technologies during the third quarter valued at approximately $84,000. Finally, Renaissance Technologies LLC boosted its position in AquaBounty Technologies by 311.9% during the 4th quarter. Renaissance Technologies LLC now owns 121,585 shares of the company’s stock worth $113,000 after acquiring an additional 92,065 shares during the period. 8.92% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 12th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, AquaBounty Technologies has a consensus rating of “Sell”.

AquaBounty Technologies Price Performance

Shares of NASDAQ:AQB opened at $1.25 on Friday. The business has a 50-day moving average of $1.10 and a two-hundred day moving average of $1.00. The firm has a market capitalization of $6.44 million, a PE ratio of -1.52 and a beta of 1.39. AquaBounty Technologies has a 12 month low of $0.77 and a 12 month high of $2.95.

AquaBounty Technologies (NASDAQ:AQB) last posted its earnings results on Thursday, August 6th. The company reported ($0.26) earnings per share for the quarter.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.